Please login to the form below

Not currently logged in
Email:
Password:

BRIC doctors increase social networking

Physicians in the emerging BRIC countries are incorporating social networks and online communities into their professional resources, according to a study from Manhattan Research

Physicians in the emerging BRIC (Brazil, Russia, India, China) countries, particularly in Russia and India, are incorporating social networks and online communities into their professional resources, according to a study from Manhattan Research.

This trend is likely due in part to user-generated content from peers filling a gap in the availability of online clinical resources in some of these high growth pharma markets, it said.

Among physicians who are already online for professional purposes in Russia and India, more than half have used a social network or online community for a professional reason in the past year.

Adoption is more moderate in China and Brazil; however physicians in these countries are stronger users of social networking for their work and learning than those in more mature pharma markets, such as Canada and Japan.

Monique Levy, vice president of research at Manhattan Research, said: "It's fascinating to watch physician social media in different markets. In the US and Europe, it has grown very slowly mostly because physicians are highly satisfied with the clinical content they already access online.

"However, in less mature content markets – where physicians are still hungry for clinical information and peer knowledge – these networks are thriving."

The findings come from Manhattan Research's Taking the Pulse BRIC study.

1st June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics